These antibodies can have a direct impact on muscle tissues that express HMGCR, leading to symptoms such as myalgia, myopathy, myonecrosis, and significant muscle fiber necrosis, as evidenced by muscle biopsy results (Brunham et al., 2018). This evidence concerns the gene HMGCR and myopathy.